Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1950 3
1951 1
1952 2
1954 2
1956 3
1957 5
1958 3
1959 3
1961 3
1962 4
1963 2
1964 4
1965 2
1966 8
1967 9
1968 3
1969 9
1970 3
1971 3
1972 5
1973 6
1974 12
1975 5
1976 9
1977 9
1978 9
1979 12
1980 8
1981 7
1982 14
1983 12
1984 12
1985 10
1986 10
1987 5
1988 13
1989 9
1990 23
1991 22
1992 37
1993 35
1994 26
1995 32
1996 25
1997 27
1998 22
1999 37
2000 40
2001 44
2002 41
2003 33
2004 45
2005 39
2006 32
2007 29
2008 26
2009 51
2010 41
2011 39
2012 47
2013 49
2014 98
2015 100
2016 106
2017 112
2018 97
2019 104
2020 125
2021 104
2022 85
2023 143
2024 64

Text availability

Article attribute

Article type

Publication date

Search Results

2,113 results

Results by year

Filters applied: . Clear all
Page 1
Coronary Microvascular Disease in Contemporary Clinical Practice.
Smilowitz NR, Toleva O, Chieffo A, Perera D, Berry C. Smilowitz NR, et al. Circ Cardiovasc Interv. 2023 Jun;16(6):e012568. doi: 10.1161/CIRCINTERVENTIONS.122.012568. Epub 2023 Jun 1. Circ Cardiovasc Interv. 2023. PMID: 37259860 Review.
Beyond ischemia with nonobstructive coronary artery disease, testing for CMD may play a role in patients with acute myocardial infarction, angina following coronary revascularization, heart failure with preserved ejection fraction, Takotsubo syndrome, and after heart …
Beyond ischemia with nonobstructive coronary artery disease, testing for CMD may play a role in patients with acute myocardial infarction, a …
Epigenetic Signatures of Cigarette Smoking.
Joehanes R, Just AC, Marioni RE, Pilling LC, Reynolds LM, Mandaviya PR, Guan W, Xu T, Elks CE, Aslibekyan S, Moreno-Macias H, Smith JA, Brody JA, Dhingra R, Yousefi P, Pankow JS, Kunze S, Shah SH, McRae AF, Lohman K, Sha J, Absher DM, Ferrucci L, Zhao W, Demerath EW, Bressler J, Grove ML, Huan T, Liu C, Mendelson MM, Yao C, Kiel DP, Peters A, Wang-Sattler R, Visscher PM, Wray NR, Starr JM, Ding J, Rodriguez CJ, Wareham NJ, Irvin MR, Zhi D, Barrdahl M, Vineis P, Ambatipudi S, Uitterlinden AG, Hofman A, Schwartz J, Colicino E, Hou L, Vokonas PS, Hernandez DG, Singleton AB, Bandinelli S, Turner ST, Ware EB, Smith AK, Klengel T, Binder EB, Psaty BM, Taylor KD, Gharib SA, Swenson BR, Liang L, DeMeo DL, O'Connor GT, Herceg Z, Ressler KJ, Conneely KN, Sotoodehnia N, Kardia SL, Melzer D, Baccarelli AA, van Meurs JB, Romieu I, Arnett DK, Ong KK, Liu Y, Waldenberger M, Deary IJ, Fornage M, Levy D, London SJ. Joehanes R, et al. Circ Cardiovasc Genet. 2016 Oct;9(5):436-447. doi: 10.1161/CIRCGENETICS.116.001506. Epub 2016 Sep 20. Circ Cardiovasc Genet. 2016. PMID: 27651444 Free PMC article.
BACKGROUND: DNA methylation leaves a long-term signature of smoking exposure and is one potential mechanism by which tobacco exposure predisposes to adverse health outcomes, such as cancers, osteoporosis, lung, and cardiovascular disorders. METHODS AND RESULTS: To comprehe …
BACKGROUND: DNA methylation leaves a long-term signature of smoking exposure and is one potential mechanism by which tobacco exposure predis …
Mortality From Ischemic Heart Disease.
Nowbar AN, Gitto M, Howard JP, Francis DP, Al-Lamee R. Nowbar AN, et al. Circ Cardiovasc Qual Outcomes. 2019 Jun;12(6):e005375. doi: 10.1161/CIRCOUTCOMES.118.005375. Epub 2019 Jun 4. Circ Cardiovasc Qual Outcomes. 2019. PMID: 31163980 Free PMC article.
Background Ischemic heart disease (IHD) has been considered the top cause of mortality globally. ...In 5 illustrative countries which provided detailed data, we analyzed trends of mortality from IHD and 3 noncommunicable diseases (lung cancer, stroke, and chronic lo …
Background Ischemic heart disease (IHD) has been considered the top cause of mortality globally. ...In 5 illustrative countries which …
Comparison of BNP and NT-proBNP in Patients With Heart Failure and Reduced Ejection Fraction.
Rørth R, Jhund PS, Yilmaz MB, Kristensen SL, Welsh P, Desai AS, Køber L, Prescott MF, Rouleau JL, Solomon SD, Swedberg K, Zile MR, Packer M, McMurray JJV. Rørth R, et al. Circ Heart Fail. 2020 Feb;13(2):e006541. doi: 10.1161/CIRCHEARTFAILURE.119.006541. Epub 2020 Feb 17. Circ Heart Fail. 2020. PMID: 32065760
BACKGROUND: Both BNP (B-type natriuretic peptide) and NT-proBNP (N-terminal pro B-type natriuretic peptide) are widely used to aid diagnosis, assess the effect of therapy, and predict outcomes in heart failure and reduced ejection fraction. However, little is known about h …
BACKGROUND: Both BNP (B-type natriuretic peptide) and NT-proBNP (N-terminal pro B-type natriuretic peptide) are widely used to aid diagnosis …
Artificial Intelligence and Machine Learning in Arrhythmias and Cardiac Electrophysiology.
Feeny AK, Chung MK, Madabhushi A, Attia ZI, Cikes M, Firouznia M, Friedman PA, Kalscheur MM, Kapa S, Narayan SM, Noseworthy PA, Passman RS, Perez MV, Peters NS, Piccini JP, Tarakji KG, Thomas SA, Trayanova NA, Turakhia MP, Wang PJ. Feeny AK, et al. Circ Arrhythm Electrophysiol. 2020 Aug;13(8):e007952. doi: 10.1161/CIRCEP.119.007952. Epub 2020 Jul 6. Circ Arrhythm Electrophysiol. 2020. PMID: 32628863 Free PMC article. Review.
Evaluating the Clinical Validity of Hypertrophic Cardiomyopathy Genes.
Ingles J, Goldstein J, Thaxton C, Caleshu C, Corty EW, Crowley SB, Dougherty K, Harrison SM, McGlaughon J, Milko LV, Morales A, Seifert BA, Strande N, Thomson K, Peter van Tintelen J, Wallace K, Walsh R, Wells Q, Whiffin N, Witkowski L, Semsarian C, Ware JS, Hershberger RE, Funke B. Ingles J, et al. Circ Genom Precis Med. 2019 Feb;12(2):e002460. doi: 10.1161/CIRCGEN.119.002460. Circ Genom Precis Med. 2019. PMID: 30681346 Free PMC article.
Influence of Ejection Fraction on Outcomes and Efficacy of Sacubitril/Valsartan (LCZ696) in Heart Failure with Reduced Ejection Fraction: The Prospective Comparison of ARNI with ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure (PARADIGM-HF) Trial.
Solomon SD, Claggett B, Desai AS, Packer M, Zile M, Swedberg K, Rouleau JL, Shi VC, Starling RC, Kozan Ö, Dukat A, Lefkowitz MP, McMurray JJ. Solomon SD, et al. Circ Heart Fail. 2016 Mar;9(3):e002744. doi: 10.1161/CIRCHEARTFAILURE.115.002744. Circ Heart Fail. 2016. PMID: 26915374 Clinical Trial.
BACKGROUND: The angiotensin receptor neprilysin inhibitor sacubitril/valsartan (LCZ696) reduced cardiovascular morbidity and mortality compared with enalapril in patients with heart failure (HF) and reduced ejection fraction (EF) in the Prospective Comparison of ARNI with …
BACKGROUND: The angiotensin receptor neprilysin inhibitor sacubitril/valsartan (LCZ696) reduced cardiovascular morbidity and mortality compa …
Predicting Stroke in Heart Failure and Preserved Ejection Fraction Without Atrial Fibrillation.
Kondo T, Jering KS, Jhund PS, Anand IS, Desai AS, Lam CSP, Maggioni AP, Martinez FA, Packer M, Petrie MC, Pfeffer MA, Redfield MM, Rouleau JL, van Veldhuisen DJ, Zannad F, Zile MR, Solomon SD, McMurray JJV. Kondo T, et al. Circ Heart Fail. 2023 Jul;16(7):e010377. doi: 10.1161/CIRCHEARTFAILURE.122.010377. Epub 2023 Jun 23. Circ Heart Fail. 2023. PMID: 37350280 Clinical Trial.
BACKGROUND: The rate of stroke in patients with heart failure (HF) and preserved ejection fraction but without atrial fibrillation (AF), is uncertain as is whether it is possible to reliably predict the risk of stroke in these patients. METHODS: We validated a previously d …
BACKGROUND: The rate of stroke in patients with heart failure (HF) and preserved ejection fraction but without atrial fibrillation (A …
Randomized Placebo-Controlled Trial of Ferric Carboxymaltose in Heart Failure With Iron Deficiency: Rationale and Design.
Mentz RJ, Ambrosy AP, Ezekowitz JA, Lewis GD, Butler J, Wong YW, De Pasquale CG, Troughton RW, O'Meara E, Rockhold FW, Garg J, Samsky MD, Leloudis D, Dugan M, Mundy LM, Hernandez AF; HEART-FID Trial Investigators. Mentz RJ, et al. Circ Heart Fail. 2021 May;14(5):e008100. doi: 10.1161/CIRCHEARTFAILURE.120.008100. Epub 2021 May 18. Circ Heart Fail. 2021. PMID: 34003690 Free PMC article.
BACKGROUND: Iron deficiency (ID) has a prevalence of 40% to 50% among patients in heart failure (HF) with reduced ejection fraction and is associated with worse prognosis. ...HEART-FID is a multicenter, randomized, double-blind, placebo-controlled trial enrolling 30 …
BACKGROUND: Iron deficiency (ID) has a prevalence of 40% to 50% among patients in heart failure (HF) with reduced ejection fraction a …
2,113 results